Exo

By  Dave Muoio 02:24 pm August 21, 2020
Exo, a Silicon Valley company known for its in-development handheld ultrasound device, announced $40 million in new funding yesterday. GlaxoSmithKline's Investor Action Potential Venture Capital fund was among the Series B+ round's unnamed investors. Exo said in its announcement that it will be using the funds to wrap up product development for that device, and to bring its data and workflow apps...
By  Laura Lovett 03:58 pm August 6, 2019
This morning AI-enabled handheld ultrasound startup Exo landed $35 million in Series B funding. The new infusion of cash was led by Intel Capital with participation from Applied Ventures, Bold Capital, Creative Ventures, Longevity Vision Fund, Magnetar Capital, Nautilus Venture Partners, OSF Healthcare, Rising Tide Fund, Sony Innovation Fund and Wanxiang Healthcare Investments.  WHAT THEY DO The...